Evidence map›Paper›PMID 27065602›Full record

ArticleJournal of parasitic diseases : official organ of the Indian Society for Parasitology2016

The anti-giardial effectiveness of fungal and commercial chitosan against Giardia intestinalis cysts in vitro.

Mohammad Yarahmadi, Mahdi Fakhar, Mohammad Ali Ebrahimzadeh, Aroona Chabra, Bahman Rahimi-Esboei

Open access · bronzeAbstract read
In one paragraph

Article in Journal of parasitic diseases : official organ of the Indian Society for Parasitology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Anticoccidial efficacy ofJournal of parasitic diseases : official organ of the Indian Society for Parasitology · 2021
    Article
  6. Article
  7. Effect of chitosan onParasite epidemiology and control · 2020
    Review
  8. Anti-International journal of nanomedicine · 2018
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Mohammad YarahmadiRazi Herbal Medicines Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran.
Mahdi FakharMolecular and Cell Biology Research Center, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
Mohammad Ali EbrahimzadehDepartment of Medicinal Chemistry, School of Pharmacy, Pharmaceutical Sciences Research Center, Mazandaran University of Medical Sciences, Sari, Iran.
Aroona ChabraFaculty of Pharmacy and Pharmaceutical Sciences Research Center, Student Research Committee, Mazandaran University of Medical Sciences, 18th kilometer of Khazar Abad Road, Sari, Iran.
Bahman Rahimi-EsboeiDepartment of Medical Parasitology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Mazandaran University of Medical Sciences · IRLorestan University of Medical Sciences · IRTehran University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chitosan with poly-N-acetylglucosamine sequences is a deacetylated derivative of chitin that can be found in the exoskeletons of crabs, shrimp and lobsters, the cuticles of insects and the cell walls of fungi. The aim of the present study was to compare the effects of fungal chitosan (FC) prepared from the cell walls of Penicillium viridicatum and Penicillium aurantiogriseum with commercially available chitosan (CC) against Giardia intestinalis cysts in vitro. The giardia cysts were isolated using a sucrose method. Four concentrations (50, 100, 200 and 400 μg/ml) of each type of prepared chitosan were applied for 10, 30, 60 and 180 min. The viability of the cysts was checked via 0.1 % eosin staining. Our results indicate that P. viridicatum (with a 47.5 % DD) and P. aurantiogriseum (with a 47.3 % DD) at different concentrations after 180 min precipitated, respectively, 56, 69, 81 and 100 %, and 63, 75, 86 and 100 % mortality rates. CC (with a 54 % DD) showed 79, 84, 93 and 100 % mortality rates. In conclusion, both FC and CC at 400 μg/ml concentrations after 180 min of exposure showed the most potent effect against G. intestinalis cysts. Accordingly, chitosan could be suggested as a new natural nanoform agent for future research in the safe and effective treatment of Giardia infections.

Indexed as

ChitosanFungiGiardia intestinalisGiardiasisPenicillium spp.

Identifiers

PMID27065602
PMCPMC4815863
OpenAlexW2501806189

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.